Tauroursodeoxycholate (dihydrate) (Standard)

CAT:
804-HY-19696BR-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tauroursodeoxycholate (dihydrate) (Standard) - image 1

Tauroursodeoxycholate (dihydrate) (Standard)

  • Description:

    Tauroursodeoxycholate (dihydrate) (Standard) is the analytical standard of Tauroursodeoxycholate (dihydrate) . This product is intended for research and analytical applications. Tauroursodeoxycholate (Tauroursodeoxycholic acid; TDUCA) dihydrate is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK[1][2].
  • Product Name Alternative:

    Tauroursodeoxycholic acid (dihydrate) (Standard) ; TUDCA (dihydrate) (Standard) ; UR 906 (dihydrate) (Standard)
  • UNSPSC:

    12352100
  • Target:

    Apoptosis; Caspase; Endogenous Metabolite; ERK; Reference Standards
  • Related Pathways:

    Apoptosis; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Others; Stem Cell/Wnt
  • Field of Research:

    Cancer
  • Smiles:

    C[C@H] (CCC (NCCS (=O) (O) =O) =O) [C@H]1CC[C@@]2 ([H]) [C@]3 ([H]) [C@@H] (O) C[C@]4 ([H]) C[C@H] (O) CC[C@]4 (C) [C@@]3 ([H]) CC[C@]12C.O.O
  • Molecular Formula:

    C26H49NO8S
  • Molecular Weight:

    535.73
  • References & Citations:

    [1]Kim SY, et al. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK viaPKCα-mediated MKP-1 induction. Cardiovasc Res. 2011 Nov 1;92 (2) :307-16.|[2]Qin Y, et al. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress. Eur J Vasc Endovasc Surg. 2017 Mar;53 (3) :337-345.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Reference Standards
  • Clinical Information:

    Launched
  • CAS Number:

    117609-50-4